2nd generation prototypes of Senses™ is currently (2010) undergoing clinical trials to evaluate the usability and performance compared to the “gold standard” EEG-video and clinical assessments of epileptic seizures. Senses™ with alarm solutions is expected to be introduced into a commercial market in 2011.
The project is supported by The Danish National Advanced Technology Foundation under the Project title: Seizures alarm and monitoring system for people with epilepsy.
The partners are:
![]() |
IctalCare |
![]() |
DELTA |
![]() |
Glostrup Hospital, Department of Clinical Neurophysiology |
![]() |
Aalborg University, |





